Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer

Eur J Cancer. 1996 Dec;32A(14):2528-33. doi: 10.1016/s0959-8049(96)00398-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Ascites / drug therapy
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Extracellular Matrix / enzymology*
  • Female
  • Humans
  • Male
  • Metalloendopeptidases / antagonists & inhibitors*
  • Mice
  • Middle Aged
  • Neoplasms / drug therapy*
  • Phenylalanine / adverse effects
  • Phenylalanine / analogs & derivatives
  • Phenylalanine / therapeutic use
  • Pleural Effusion, Malignant / drug therapy
  • Protease Inhibitors / pharmacology
  • Protease Inhibitors / therapeutic use*
  • Rats
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use

Substances

  • Antineoplastic Agents
  • Protease Inhibitors
  • Thiophenes
  • Phenylalanine
  • batimastat
  • Metalloendopeptidases